Competition will heat up in amlodipine market

The domestic amlodipine market is expected to emerge as an arena of fierce competition between domestic and foreign-invested firms from next year, market sources said recently.

Whanin Pharm, a local drug maker, unveiled on March 8 its new drug entity amlodipine salt, which was independently developed, and plans to conduct its phase I studies designed to ascertain the safety and efficacy of s...